Notably, losartan, an angiotensin receptor antagonist approved in high blood pressure treatment, may reduce the amount of TGF-β, thus constituting a potential treatment for fibrosis in EoE [87]. The gene discussed is TGFB1; the disease is eosinophilic esophagitis.